Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
HER3 and mutant EGFR meet MET
Carlos L. Arteaga
Simmons Comprehensive Cancer Center - Administration - Directors Office - Administration
Simmons Comprehensive Cancer Center
Research output
:
Contribution to journal
›
Short survey
›
peer-review
66
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'HER3 and mutant EGFR meet MET'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Phosphatidylinositol 3-Kinases
70%
ErbB Receptors
68%
Protein-Tyrosine Kinases
65%
Non-Small Cell Lung Carcinoma
64%
Phosphotransferases
55%
Cell Survival
54%
Mutation
40%
Chemical Compounds
Tyrosine Kinase Inhibitor
100%
Cell Viability
70%
Mutation
60%
Resistance
44%